SCHEMBL1916611

SCHEMBL1916611

NC(=O)CC(C(N)=O)(c1ccc(C=O)cc1)c1ccc(C=O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 1/20 0.39
PARP3 Q9Y6F1 1/20 0.39
ALDH1A1 P00352 6/20 0.38
EPHX2 P34913 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
ALDH5A1 P51649 1/20 0.38
ABAT P80404 1/20 0.38
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 2/20 0.34
CYP2A6 P11509 2/20 0.33
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.33
CHRM2 P08172 1/20 0.33
CYP2D6 P10635 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
KCNH2 Q12809 1/20 0.33
KCNN4 O15554 1/20 0.32
ALDH3A1 P30838 1/20 0.32
ALDH1A3 P47895 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1915298 0.81 KMT2A (0.39) PARP10PARP3ALDH1A1EPHX2NR1H4
SCHEMBL1915245 0.80 KMT2A (0.41) PARP10PARP3ALDH1A1EPHX2NR1H4
SCHEMBL1915600 0.79 KMT2A (0.41) PARP10PARP3ALDH1A1EPHX2NR1H4
SCHEMBL5432726 0.78 KCNN4 (0.57) ALDH1A1KMT2AKCNN4
SCHEMBL3350095 0.77 CHRM3 (0.50) KMT2AKDM4ELMNACHRM2CYP2D6
SCHEMBL1915421 0.73 ALDH1A1 (0.44) PARP10PARP3ALDH1A1EPHX2NR1H4
SCHEMBL13972885 0.72 MAPT (0.59) PARP10PARP3ALDH1A1EPHX2NR1H4
SCHEMBL18782529 0.68 KCNN4 (0.75) KMT2AKCNN4
SCHEMBL414655 0.67 CA2 (0.59) PARP10PARP3ALDH1A1ALDH5A1ABAT
SCHEMBL1916607 0.67 ALDH1A1 (0.41) ALDH1A1EPHX2NR1H4ALDH5A1ABAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018140-A1 N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKING AGENTS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES DICKMEIS MARCUS (DE) 2013-01-17 US disclosed
EP-2516531-A1 N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKERS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES Dickmeis, Marcus (DE) 2012-10-31 EP disclosed
WO-2011076392-A1 N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKERS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES DICKMEIS MARCUS (DE) 2011-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018140-A1 N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKING AGENTS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES PNN, PARN, NCLN PARP10 1203/4885PARP3 1420/4885ALDH1A1 1538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.